p53 null mutations undetected by immunohistochemical staining predict a poor outcome with early-stage non-small cell lung carcinomas

Cancer Research

Volumn 59, Issue 21, 1999, Pages 5572-5577

  Hashimoto, Takehisa ^a,d   Tokuchi, Yoshio ^a   Hayashi, Moriaki ^a   Kobayashi, Yasuhito ^a   Nishida, Kazunori ^a   Hayashi, Shin Ichi ^a   Ishikawa, Yuichi ^b   Tsuchiya, Shigehiro ^c   Nakagawa, Ken ^c   Hayashi, Jun Ichi ^d   Tsuchiya, Eiju ^a  

^a SAITAMA CANCER CENTER   (Japan)

^b CANCER INSTITUTE   (Japan)

^c CANCER INSTITUTE HOSPITAL   (Japan)

^d NIIGATA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; GENE DELETION; GENE FUNCTION; GENE INSERTION; GENE LOSS; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; PRIORITY JOURNAL; PROGNOSIS; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; DNA MUTATIONAL ANALYSIS; EXONS; FEMALE; GENES, P53; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MIDDLE AGED; MUTATION; MUTATION, MISSENSE; PROGNOSIS; TIME FACTORS;

EID: 0033229836     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Parkin, D. M., Pisani, P., and Ferlay, J. Estimates of the world wide incidence of eighteen major cancers in 1985. Int. J. Cancer, 54: 594-606, 1993.
2. Travis, W. D., Travis, L. B., and Devesa, S. S. Lung cancer. Cancer (Phila.), 75 (Suppl 1): 191-202, 1995.
3. Ministry of Health and Welfare. Statistics and Information Department. Vital statistics 1990 Japan. Tokyo: Ministry of Health and Welfare, 1997.
4. WHO. The World Health Organization histological typing of lung tumors, ed. 2. Am. J. Clin. Pathol., 77: 123-136, 1982.
5. Naruke, T., Goya, T., Tsuchiya, R., and Suemasu, K. Prognosis and survival in resected lung carcinoma based on the new international staging system. J. Thorac. Cardiovasc. Surg., 96: 440-447, 1988.
6. Lane, D. P. p53, guardian of the genome. Nature (Lond.), 358: 15-16, 1992.
7. Harris, C. C., and Hollstein, M. Clinical implications of the p53 tumor-suppressor gene. New Engl. J. Med., 329: 1318-1327, 1993.
8. Greenblatt, M. S., Bennett, W. P., Hollstein, M., and Harris, C. C. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res., 54: 4855-4878, 1994.
9. Nigro, J. M., Baker, S. J., Preisinger, A. C., Jessup, J. M., Hostetter, R., Cleary, K., Bigner, S. H., Davidson, N., Baylin, S., Devilee, P., Glover, T., Collins, F. S., Weston, A., Modali, R., Harris, C. C., and Vogelstein, B. Mutations in the p53 gene occur in diverse human tumor types. Nature (Lond.), 342: 705-708, 1989.
10. Takahashi, T., Nau, M. M., Chiba, I., Birrer, M. J., Rosenberg, R. K., Vinocour, M., Levitt, M., Pass, H., Gazdar, A. F., and Minna, J. D. p53: a frequent target for genetic abnormalities in lung cancer. Science (Washington DC), 246: 491-494, 1989.
11. Iggo, R., Gatter, K., Bartek, J., Lane, D., and Harris, A. L. Increased expression of mutant forms of p53 oncogene in primary lung cancer. Lancet, 335: 675-679, 1990.
12. Hartmann, A., Blaszyk, H., McGovern, R. M., Schroeder, J. J., Cunningham, J., De Vries, E. M., Kovach, J. S., and Sommer, S. S. p53 gene mutations inside and outside of exons 5-8: the patterns differ in breast and other cancers. Oncogene, 10: 681-688, 1995.
13. Casey, G., Lopez, M. E., Ramos, J. C., Plummer, S. J., Arboleda, M. J., Shaughnessy, M., Karlan, B., and Slamon, D. DNA sequence analysis of exon 2 through 11 and immunohistochemical staining are required to detect all known p53 alterations in human malignancies. Oncogene, 13: 1971-1981, 1996.
14. Bodner, S. M., Minna, J. D., Jensen, S. M., D'Amico, D., Carbone, D., Mitsudomi, T., Fedorko, J., Buchhagen, D. L., Nau, M. M., Gazdar, A. F., and Linnoila, R. I. Expression of mutant p53 proteins in lung cancer correlates with the class of p53 gene mutation. Oncogene, 7: 743-749, 1992.
15. Quinlan, D. C., Davidson, A. G., Summers, C. L., Warden, H. E., and Doshi, H. M. Accumulation of p53 protein correlates with a poor prognosis in human lung cancer. Cancer Res., 52: 4828-4831, 1992.
16. McLaren, R., Kuzu, I., Dunnill, M., Harris, A., Lane, D., and Gatter, K. C. The relationship of p53 immunostaining to survival in carcinoma of the lung. Br. J. Cancer, 66: 735-738, 1992.
17. Brambilla, E., Gazzeri, S., Moro, D., De Fromentel, C. C., Gouyer, V., Jacrot, M., and Brambilla, C. Immunohistochemical study of p53 in human lung carcinomas. Am. J. Pathol., 143: 199-210, 1993.
18. Mitsudomi, T., Oyama, T., Kusano, T., Osaki, T., Nakanishi, R., and Shirakusa, T. Mutations of the p53 gene as a predictor of poor prognosis in patients with non-small-cell lung cancer. J. Natl. Cancer Inst., 85: 2018-2023, 1993.
19. Fong, K. M., Kida, Y., Zimmerman, P. V., Ikenaga, M., and Smith, P. Loss of heterozygosity frequently affects chromosome 17q in non-small cell lung cancer. Cancer Res., 55: 4268-4272, 1995.
20. Carbone, D. P., Mitsudomi, T., Chiba, I., Piantadosi, S., Rusch, V., Nowak, J. A., McIntire, D., Salmon, D., Gazdar, A., and Minna, J. p53 immunostaining positivity is associated with reduced survival and is imperfectly correlated with gene mutations in resected non-small cell lung cancer. A preliminary report of LCSG 871. Chest, 106: 377S-381S, 1994.
21. Ebina, M., Steinberg, S. M., Mulshine, J. L. Linnoila, R. I. Relationship of p53 overexpression and up-regulation of proliferating cell nuclear antigen with the clinical course of non-small cell lung cancer. Cancer Res., 54: 2496-2503, 1994.
22. Harpole, D. H., Jr., Marks, J. R., Richards, W. G., Herndon, J. E., II, and Sugarbaker, D. J. Localized adenocarcinoma of the lung: oncogene expression of erbB-2 and p53 in 150 patients. Clin. Cancer Res., 1: 659-664, 1995.
23. Lee, J. S., Yoon, A., Kalapurakal, S. K., Ro, J. Y., Lee, J. J., Tu, N., Hittelman, W. N., and Hong, W. K. Expression of p53 oncoprotein in non-small-cell lung cancer: a favorable prognostic factor. J. Clin. Oncol., 13: 1893-1903.
24. Nishio, M., Koshikawa, T., Kuroishi, T., Suyama, M., Uchida, K., Takagi, Y., Washimi, O., Sugiura, T., Ariyoshi, Y., Takahashi, T., Ueda, R., and Takahashi, T. Prognostic significance of abnormal p53 accumulation in primary non-small-cell lung cancers. J. Clin. Oncol., 14: 497-502, 1996.
25. Pastorino, U., Andreola, S., Tagliabue, E., Pezzella, F., Incarbone, M., Sozzi, G., Buyse, M., Menard, S., Picrotti, M., and Rilke, F. Immunocytochemical markers in stage I lung cancer: relevance to prognosis. J. Clin. Oncol., 15: 2858-2865, 1997.
26. Vega, F. J., Iniesta, P., Caldés, T., Sánchez, A., López, J. A., De Juan, C., Diaz-Rubio, E., Torres, A., Balibrea, J. L., and Benito, M. p53 exon 5 mutations as a prognostic indicator of shortened survival in non-small-cell lung cancer. Br. J. Cancer, 76: 44-51, 1997.
27. De Anta, J. M., Jassem, E., Rosell, R., Martínez-Roca, M., Jassem, J., Martínez-López, E., Monzó, M., Sánchez-Hernández, J. J., Moreno, I., and Sánchez-Céspedes, M. TP53 mutational pattern in Spanish and Polish non-small cell lung cancer patients: null mutations are associated with poor prognosis. Oncogene, 15: 2951-2958, 1997.
28. Tomizawa, Y., Kohno, T., Fujita, T., Kiyama, M., Saito, R., Noguchi, M., Matsuno, Y., Hirohashi, S., Yamaguchi, N., Nakajima, T., and Yokota, J. Correlation between the status of the p53 gene and survival in patients with stage I non-small cell lung carcinoma. Oncogene, 18: 1007-1014, 1999.
29. Dix, B., Robbins, P., Carrello, S., House, A., and Iacopetta, B. Comparison of p53 gene mutation and protein overexpression in colorectal carcinomas. Br. J. Cancer, 70: 585-590, 1994.
30. Mineta, H., Borg, Å., Dictor, M., Wahlberg, P., Åkervall, J., and Wennerberg, J. p53 mutation, but not p53 overexpression, correlates with survival in head and neck squamous cell carcinoma. Br. J. Cancer, 78: 1084-1090, 1998.
31. Union Internationale Contre le Cancer (UICC). Lung tumors. In: P. Hermanek and L. H. Sobin (eds.), TNM Classification of Malignant Tumors, 4th ed., pp. 70-73. Berlin: Springer-Verlag, 1987.
32. Tsuchiya, E., Nakamura, Y., Weng, S-Y., Nakagawa, K., Tsuchiya, S., Sugano, H., and Kitagawa, T. Allelotype of non-small cell lung carcinoma: comparison between loss of heterozygosity in squamous cell carcinoma and adenocarcinoma. Cancer Res., 52: 2478-2481, 1992.
33. Orita, M., Iwahana, H., Kanazawa, H., Hayashi, K., and Sekiya, T. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc. Natl. Acad. Sci. USA, 86: 2766-2770, 1989.
34. Tokuchi, Y., Hashimoto, T., Kobayashi, Y., Hayashi, M., Nishida, K., Hayashi, S., Imai, K., Nakachi, K., Ishikawa, Y., Nakagawa, K., Kawakami, Y., and Tsuchiya, E. The expression of p73 is increased in lung cancer, independent of p53 gene alteration. Br. J. Cancer, 80: 1623-1629, 1999.
35. Kawai, K., Noguchi, M., Beppu, Y., Yokoyama, R., Mukai, K., Hirohashi, S., Inoue, H., and Fukuma, H. Nuclear immunoreaction of p53 protein in soft tissue sarcomas. A possible prognostic factor. Cancer (Phila.), 73: 2499-2505, 1994.
36. Nakanishi, K., Kawai, T., and Torikata, C. Immunohistochemical evaluation of p53 oncoprotein in transitional cell carcinoma of the upper urinary tract. Hum. Pathol., 27: 1336-1340, 1996.
37. Kawasaki, M., Noguchi, M., Morikawa, A., Matsuno, Y., Yamada, T., Hirohashi, S., Kondo, H., and Shimosato, Y. Nuclear p53 accumulation by small-sized adenocarcinomas of the lung. Pathol. Int., 46: 486-490, 1996.
38. Matlashewsky, G. J., Tuck, S., Pim, D., Lamb, P., Schneider, J., and Crawford, L. V. Primary structure polymorphism at amino acid residue 72 of human p53. Mol. Cell. Biol., 7: 961-963, 1987.
39. Kishimoto, Y., Murakami, Y., Shiraishi, M., Hayashi, K., and Sekiya, T. Aberrations of the p53 tumor suppressor gene in human non-small cell carcinomas of the lung. Cancer Res., 52: 4799-4804, 1992.
40. Selivanova, G., Iotsova, V., Okan, I., Fritsche, M., Ström, M., Groner, B., Grafström, R. C., and Wiman, K. G. Restoration of the growth suppression function of mutant p53 by a synthetic peptide derived from the p53 C-terminal domain. Nat Med., 3: 632-638, 1997.
41. Zhou, X., Wang, X. W., Xu, L., Hagiwara, K., Nagashima, M., Wolkowicz, R., Zurer, I., Rotter, V., and Harris, C. C. COOH-terminal domain of p53 modulates p53-mediated transcriptional transactivation, cell growth, and apoptosis. Cancer Res., 59: 843-848, 1999.